Systematic Review on Treatment and Outcomes of Tuberculous Peritonitis in Patients on Peritoneal Dialysis

被引：0
作者：
Ling, Chau Wei [1 ]
Sud, Kamal [2 ,3 ,4 ]
Castelino, Ronald L. [1 ,5 ]
Johnson, David W. [4 ,6 ,7 ,8 ]
Tan, Trevor H. Y. [9 ]
Lee, Vincent W. [10 ,11 ,12 ,13 ]
机构：
[1] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[2] Nepean Hosp, Nepean Kidney Res Ctr, Dept Renal Med, Sydney, NSW, Australia
[3] Blacktown Hosp, Reg Dialysis Ctr, Peritoneal Dialysis Unit, Sydney, NSW, Australia
[4] Australia & New Zealand Dialysis & Transplant ANZD, Peritoneal Dialysis Working Grp, Adelaide, SA, Australia
[5] Blacktown Hosp, Dept Pharm, Blacktown, NSW, Australia
[6] Univ Queensland, Australasian Kidney Trials Network, Brisbane, Australia
[7] Princess Alexandra Hosp, Dept Kidney & Transplant Serv, Brisbane, Australia
[8] Translat Res Inst, Brisbane, Australia
[9] Natl Ctr Infect Dis, Singapore, Singapore
[10] Westmead Hosp, Dept Renal Med, Westmead, NSW, Australia
[11] Univ Sydney, Fac Med & Hlth, Westmead Appl Res Ctr, Sydney, Australia
[12] Univ Sydney, Ctr Kidney Res, Sch Publ Hlth, Sydney, NSW, Australia
[13] Westmead Hosp, Fac Med & Hlth, Westmead Appl Res Ctr, Dept Renal Med, Westmead, NSW 2006, Australia
来源：
KIDNEY INTERNATIONAL REPORTS | 2024年 / 9卷 / 02期
关键词：
antituberculosis regimen; Mycobacterium tuberculosis; outcomes; peritoneal dialysis; peritonitis; treatment; CATHETER REMOVAL;
D O I：
10.1016/j.ekir.2023.11.012
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Introduction: Peritoneal dialysis (PD) -associated peritonitis due to tuberculosis (TB) is associated with poor outcomes and optimal treatment strategies for this condition remain unknown. Our study aimed to: (i) systematically review the published literature on peritonitis caused by Mycobacterium tuberculosis in patients on PD and (ii) review cases of peritonitis due to M tuberculosis in patients on PD reported in Australia and New Zealand to determine the epidemiology, management strategies, and outcomes of this condition. Methods: A literature search of Medline, Scopus, Embase, ClinicalTrials.gov, Cochrane CENTRAL Register of Controlled Trials and Google Scholar for articles published from inception date to June 2022 was conducted. To be eligible, articles had to describe patient characteristics, initial anti -TB therapy, and treatment outcomes in all patients on PD with peritonitis caused by M tuberculosis. Data from the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry of patients on PD who developed peritonitis due to M tuberculosis between September 2001 and December 2020 were included and analyzed. Results: The systematic literature review identified 70 case studies (151 patients) and 8 cohort studies (97 patients), whereas the ANZDATA Registry identified 17 cases of peritonitis due to M tuberculosis. Overall, in patients diagnosed with peritonitis due to M tuberculosis, the rates of PD catheter removal and permanent transfer to hemodialysis (HD) were numerically higher in the ANZDATA Registry cases (82%) than in the case studies (23%) and cohort studies (20%). Observed all -cause mortality rates were also higher as observed in the case studies (33%) and cohort studies (26%) than in the ANZDATA Registry cases (6%). Conclusion: Tuberculous peritonitis is uncommon in patients on PD and is associated with poor outcomes. Prospective studies are warranted to study the effect of retaining PD catheters after M tuberculosis infection on patient outcomes.
引用
收藏
页码：277 / 286
页数：10
相关论文
共 27 条
[1]  
Ahn C, 2003, PERITON DIALYSIS INT, V23, P362
[2]  
Akpolat T, 2009, PERITON DIALYSIS INT, V29, pS166
[3]  
[Anonymous], WHO global lists of high burden countries for tuberculosis (TB), TB/HIV and multidrug/rifampicin-resistant TB (MDR/RR-TB), 2021-2025
[4]  
Australia & New Zealand dialysis & transplant registry (ANZDATA), Data forms
[5]   Biofilms and Mycobacterium tuberculosis [J].
Brennan, Michael J. .
INFECTION AND IMMUNITY, 2017, 85 (10)
[6]   Relapsing and Recurrent Peritoneal Dialysis-Associated Peritonitis: A Multicenter Registry Study [J].
Burke, Michael ;
Hawley, Carmel M. ;
Badve, Sunil V. ;
McDonald, Stephen P. ;
Brown, Fiona G. ;
Boudville, Neil ;
Wiggins, Kathryn J. ;
Bannister, Kym M. ;
Johnson, David W. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 58 (03) :429-436
[7]   Mycobacterium Biofilms [J].
Esteban, Jaime ;
Garcia-Coca, Marta .
FRONTIERS IN MICROBIOLOGY, 2018, 8
[8]   Nutritional status of tuberculosis patients, a comparative cross-sectional study [J].
Feleke, Berhanu Elfu ;
Feleke, Teferi Elfu ;
Biadglegne, Fantahun .
BMC PULMONARY MEDICINE, 2019, 19 (01)
[9]  
Khanna R, 1980, Perit Dial Int, V1, P10, DOI [10.1177/089686088000100302, DOI 10.1177/089686088000100302]
[10]   ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment [J].
Li, Philip Kam-Tao ;
Chow, Kai Ming ;
Cho, Yeoungjee ;
Fan, Stanley ;
Figueiredo, Ana E. ;
Harris, Tess ;
Kanjanabuch, Talerngsak ;
Kim, Yong-Lim ;
Madero, Magdalena ;
Malyszko, Jolanta ;
Mehrotra, Rajnish ;
Okpechi, Ikechi G. ;
Perl, Jeff ;
Piraino, Beth ;
Runnegar, Naomi ;
Teitelbaum, Isaac ;
Wong, Jennifer Ka-Wah ;
Yu, Xueqing ;
Johnson, David W. .
PERITONEAL DIALYSIS INTERNATIONAL, 2022, 42 (02) :110-153
123